# Digital Pathology Market Report: Size, Share & Trends 2026–2035

> The Global Digital Pathology market was valued at USD 1,378.5 Mn in 2025 and is projected to reach USD 4,175.6 Mn by 2035, an 11.72% CAGR over 2026–2035, according to Vectomat Insights. North America leads with a 40.0% share. Software & Analytics is the largest product segment at 42.0%, while Storage & Communication Systems grow fastest, at 17.41% a year.

- Publisher: Vectomat Insights
- Report code: VMI-1-3-37694
- Published: 2026-11-09
- Canonical URL: https://www.vectomatinsights.com/report/digital-pathology-market
- Base year 2025: USD 1,378.5 Mn
- Forecast 2035: USD 4,175.6 Mn
- CAGR 2026–2035: 11.72%

## Key insights

- The Global Digital Pathology market rises from USD 1,378.5 Mn in 2025 to USD 4,175.6 Mn by 2035, an 11.72% CAGR that roughly triples the market inside the forecast horizon.
- Software & Analytics is the dominant product segment at 42.0% of 2025 revenue (USD 579.0 Mn), because image management, viewing and AI licences recur every year while scanners are bought once.
- Storage & Communication Systems is the fastest-growing product segment at a 17.41% CAGR, lifting its revenue from USD 193.0 Mn in 2025 to USD 960.5 Mn by 2035 as whole-slide image archives swell.
- Cancer Diagnosis is the dominant application at 46.0% of 2025 revenue (USD 634.1 Mn), since prostate, breast and gastrointestinal biopsies are where FDA-cleared and CE-IVD algorithms are most mature.
- Hospitals & Diagnostic Labs are the dominant end user at 50.0% of 2025 revenue and also the fastest-growing at a 15.14% CAGR, driven by pathologist shortages and the shift to remote sign-out.
- North America leads all regions with a 40.0% share in 2025 (USD 551.4 Mn), and the United States alone accounts for USD 452.1 Mn.
- Asia Pacific is the fastest-growing region, with South Korea forecast at a 13.9% CAGR and Japan at 12.0%, both ahead of the United States at 10.5%.
- Consolidation is redrawing the vendor map: Roche agreed to acquire PathAI for up to USD 1.05 Bn in May 2026, and Agilent completed its purchase of Proscia, agreed in October 2026 for up to USD 270 Mn.
- Hybrid deployment is the fastest-growing model at an 18.0% CAGR, and VMI expects cloud and hybrid together to exceed 65% of deployment revenue by 2035 as labs move archives off local servers.

## Figures

![Digital pathology market size — USD 1,378.5 Mn (2025) to USD 4,175.6 Mn (2035), 11.72% CAGR | Vectomat Insights](https://vectomat-media-prod.tor1.cdn.digitaloceanspaces.com/reports/digital-pathology-market/b023dd4346db6663/digital-pathology-market-size-vmi.png) — The Global Digital Pathology market grows from USD 1,378.5 Mn in 2025 to USD 4,175.6 Mn by 2035, an 11.72% CAGR. Source: Vectomat Insights, Digital Pathology Market Report.
![Digital pathology market drivers, restraints, opportunities and challenges | Vectomat Insights](https://vectomat-media-prod.tor1.cdn.digitaloceanspaces.com/reports/digital-pathology-market/b023dd4346db6663/digital-pathology-market-droc-vmi.png) — Pathologist shortages, cleared end-to-end systems and AI consolidation drive the market, while capital cost and storage load restrain it. Source: Vectomat Insights, Digital Pathology Market Report.
![Digital pathology market share by region — North America leads with 40.0% in 2025 | Vectomat Insights](https://vectomat-media-prod.tor1.cdn.digitaloceanspaces.com/reports/digital-pathology-market/b023dd4346db6663/digital-pathology-market-regional-share-vmi.png) — North America holds 40.0% of the 2025 Digital Pathology market, and Asia Pacific is the fastest-growing region. Source: Vectomat Insights, Digital Pathology Market Report.
![Digital pathology market segmentation — Software & Analytics leads product revenue at 42.0% | Vectomat Insights](https://vectomat-media-prod.tor1.cdn.digitaloceanspaces.com/reports/digital-pathology-market/b023dd4346db6663/digital-pathology-market-segments-vmi.png) — Software & Analytics, Cancer Diagnosis, Hospitals & Diagnostic Labs and On-Premise deployment lead their dimensions in 2025. Source: Vectomat Insights, Digital Pathology Market Report.
![Digital pathology market share by product — Software & Analytics 42.0% in 2025 | Vectomat Insights](https://vectomat-media-prod.tor1.cdn.digitaloceanspaces.com/reports/digital-pathology-market/b023dd4346db6663/digital-pathology-market-product-share-vmi.png) — Software & Analytics accounts for 42.0% of 2025 Digital Pathology revenue, ahead of Scanners at 34.0%. Source: Vectomat Insights, Digital Pathology Market Report.
![Digital pathology market share by end user — Hospitals & Diagnostic Labs 50.0% in 2025 | Vectomat Insights](https://vectomat-media-prod.tor1.cdn.digitaloceanspaces.com/reports/digital-pathology-market/b023dd4346db6663/digital-pathology-market-end-user-share-vmi.png) — Hospitals & Diagnostic Labs account for half of 2025 Digital Pathology revenue and are the fastest-growing end user. Source: Vectomat Insights, Digital Pathology Market Report.
![Digital pathology product mix by region — North America, Europe, Asia Pacific | Vectomat Insights](https://vectomat-media-prod.tor1.cdn.digitaloceanspaces.com/reports/digital-pathology-market/b023dd4346db6663/digital-pathology-market-regional-segments-vmi.png) — Software & Analytics takes the largest product share in all three leading regions, while Asia Pacific spends proportionally more on scanners. Source: Vectomat Insights, Digital Pathology Market Report.
![Digital pathology competitive positioning — 14 companies by installed base and workflow coverage | Vectomat Insights](https://vectomat-media-prod.tor1.cdn.digitaloceanspaces.com/reports/digital-pathology-market/b023dd4346db6663/digital-pathology-market-competitive-landscape-vmi.png) — Leica Biosystems, Roche Diagnostics and Philips combine broad clinical installed bases with end-to-end workflow coverage. Source: Vectomat Insights, Digital Pathology Market Report.
![Digital pathology market at a glance — USD 1,378.5 Mn (2025) to USD 4,175.6 Mn, 11.72% CAGR | Vectomat Insights](https://vectomat-media-prod.tor1.cdn.digitaloceanspaces.com/reports/digital-pathology-market/b023dd4346db6663/digital-pathology-market-key-numbers-vmi.png) — The Digital Pathology market triples to USD 4,175.6 Mn by 2035, led by North America and Software & Analytics. Source: Vectomat Insights, Digital Pathology Market Report.
![United States digital pathology market — USD 452.1 Mn (2025) to USD 1,227.0 Mn (2035) | Vectomat Insights](https://vectomat-media-prod.tor1.cdn.digitaloceanspaces.com/reports/digital-pathology-market/b023dd4346db6663/digital-pathology-market-united-states-snapshot-vmi.png) — The United States Digital Pathology market grows from USD 452.1 Mn in 2025 to USD 1,227.0 Mn by 2035 at a 10.5% CAGR. Source: Vectomat Insights, Digital Pathology Market Report.
![Germany digital pathology market — USD 96.8 Mn (2025) to USD 253.4 Mn (2035) | Vectomat Insights](https://vectomat-media-prod.tor1.cdn.digitaloceanspaces.com/reports/digital-pathology-market/b023dd4346db6663/digital-pathology-market-germany-snapshot-vmi.png) — The Germany Digital Pathology market grows from USD 96.8 Mn in 2025 to USD 253.4 Mn by 2035 at a 10.1% CAGR. Source: Vectomat Insights, Digital Pathology Market Report.
![South Korea digital pathology market — USD 66.6 Mn (2025) to USD 244.7 Mn (2035) | Vectomat Insights](https://vectomat-media-prod.tor1.cdn.digitaloceanspaces.com/reports/digital-pathology-market/b023dd4346db6663/digital-pathology-market-south-korea-snapshot-vmi.png) — The South Korea Digital Pathology market grows from USD 66.6 Mn in 2025 to USD 244.7 Mn by 2035 at a 13.9% CAGR. Source: Vectomat Insights, Digital Pathology Market Report.

## Market size (USD million)

| Year | Value |
|---|---|
| 2023 | 1,096.8 |
| 2024 | 1,232.4 |
| 2025 | 1,378.5 |

## Share by Product (2025)

| Segment | Share | USD Mn |
|---|---|---|
| Software & Analytics | 42% | 579.0 |
| Scanners | 34% | 468.7 |
| Storage & Communication Systems | 14% | 193.0 |
| Services | 10% | 137.8 |

## Share by Application (2025)

| Segment | Share | USD Mn |
|---|---|---|
| Cancer Diagnosis | 46% | 634.1 |
| Drug Discovery & Development | 26% | 358.4 |
| Disease Research | 16% | 220.6 |
| Others (Education and training, clinical diagnostics for non-cancer disease, and veterinary/forensic pathology) | 12% | 165.4 |

## Share by End User (2025)

| Segment | Share | USD Mn |
|---|---|---|
| Hospitals & Diagnostic Labs | 50% | 689.2 |
| Pharma & Biotech Companies | 30% | 413.6 |
| Academic & Research Institutes | 20% | 275.7 |

## Share by Deployment (2025)

| Segment | Share | USD Mn |
|---|---|---|
| On-Premise | 47.8% | 658.5 |
| Cloud-Based | 38% | 523.8 |
| Hybrid | 14.2% | 196.2 |

## Regional share

| Region | Share | USD Mn |
|---|---|---|
| North America | 40% | 551.4 |
| Europe | 26.14% | 360.3 |
| Asia Pacific | 23% | 317.1 |
| Latin America | 5% | 68.9 |
| The Middle East | 3.05% | 42.1 |
| Africa | 2.81% | 38.8 |

## Key companies

- Leica Biosystems (Danaher) (Germany): Whole-slide scanners (Aperio GT 450 DX, GT 180 DX) and image management
- Roche Diagnostics (Switzerland): navify Digital Pathology, VENTANA DP scanners and companion-diagnostic algorithms
- Philips (Netherlands): IntelliSite Pathology Solution (scanner, image management, AI integration)
- Hamamatsu Photonics (Japan): NanoZoomer MD slide scanners, OEM supply to partners
- Agilent Technologies (U.S.): S540MD slide scanner (Hamamatsu OEM) and pathology staining workflow
- PathAI (U.S.): AISight Dx image management and AI algorithms for diagnosis and drug development
- Tempus AI (Paige) (U.S.): Paige Prostate, Paige PanCancer Detect and pathology foundation models
- Proscia (U.S.): Concentriq image management platform for clinical labs and pharma
- Sectra (Sweden): Enterprise imaging and digital pathology PACS, Image Exchange Portal
- Ibex Medical Analytics (Israel): AI cancer detection and grading (Galen platform)
- Aiforia Technologies (Finland): Cloud AI image analysis for clinical and research pathology
- Visiopharm (Grundium) (Denmark): AI precision pathology and biomarker quantification software
- Indica Labs (U.S.): HALO image analysis and HALO AP image management
- OptraSCAN (U.S.): OS-Ultra whole-slide scanners and ImagePath software with HER2 analysis

## FAQs

### What does the VMI Digital Pathology report include?

The report includes market sizing for 2023–2025 and forecasts to 2035, segment tables by Product, Application, End User and Deployment, a Production & Volume analysis, six regional sections with 35+ country coverage, a full drivers-restraints-opportunities-challenges analysis, a 14-company competitive table, value chain analysis, policy review and recent developments. It runs to 300+ pages with 96 tables and 70 figures, according to Vectomat Insights.

### What is the Digital Pathology market size and forecast?

Vectomat Insights values the Global Digital Pathology market at USD 1,378.5 Mn in 2025 and forecasts USD 4,175.6 Mn by 2035, an 11.72% CAGR across the 2026–2035 forecast period. Hospitals & Diagnostic Labs are both the largest and fastest-growing end user, at 50.0% of 2025 revenue and a 15.14% CAGR, while Hybrid is the fastest-growing deployment model at 18.0% a year, according to Vectomat Insights.

### How is the Digital Pathology market segmented in this report?

The report segments the market by Product (Software & Analytics, Scanners, Storage & Communication Systems, Services), by Application (Cancer Diagnosis, Drug Discovery & Development, Disease Research, Others), by End User (Hospitals & Diagnostic Labs, Pharma & Biotech Companies, Academic & Research Institutes) and by Deployment (On-Premise, Cloud-Based, Hybrid), plus six regions, with segment revenue tables for 2023–2025, according to Vectomat Insights.

### Which countries are covered in this report?

The report covers 35+ countries across six regions: North America (U.S., Canada, Mexico), Europe (Germany, France, U.K., Italy, Spain and others), Asia Pacific (China, Japan, India, South Korea, Australia and others), Latin America (Brazil, Argentina, Colombia, Chile, Peru), the Middle East (GCC states, Israel, Turkey, Iran) and Africa (South Africa, Egypt, Nigeria, Algeria, Morocco). Detailed snapshots cover the U.S., Germany and South Korea, according to Vectomat Insights.

### What customization options are available?

Buyers can request up to 10% free customization. Typical requests include extra country splits, additional company profiles, and deeper sub-segment cuts, such as scanner throughput class, AI algorithm category or cloud provider. Further custom work, including installed-base tracking or buyer surveys among pathology lab directors, is available on request through the Vectomat Insights sales team at sales@vectomatinsights.com, according to Vectomat Insights.

### How can I access or purchase the Digital Pathology report?

You can request a free sample, raise a pre-purchase inquiry or buy the full Digital Pathology Market Report at www.vectomatinsights.com. The report is delivered as a PDF by email and through an online download portal, and customization requests can be agreed before purchase. For corporate licences or bulk orders, contact the team directly at sales@vectomatinsights.com for pricing and licence terms, according to Vectomat Insights.

### What research methodology does VMI use for this report?

VMI combines a bottom-up model of scanner placements, software and AI licences, storage installations and service contracts with a top-down check against reported vendor revenue. Primary interviews with lab directors, hospital IT leads and vendor product managers are triangulated with FDA 510(k) and IVDR records, company filings and the 2026 Labcorp pathologist survey, and every segment and regional table is reconciled to the base-year total, according to Vectomat Insights.

Cite as: Vectomat Insights (2026). Digital Pathology Market Report. https://www.vectomatinsights.com/report/digital-pathology-market